I would suggest reading through the recent F1 filings / SEC applications for the Nasdaq listing. This is the most comprehensive / up to date view of were the company is at / past results etc.https://sec.report/Document/0001213900-21-063993/
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress